Roger Jeffs, Director at Axsome Therapeutics, Inc. (AXSM), sold 53,388 shares at $120.03 ($6.4M) on 2025-08-26, disclosed to the SEC on 2025-08-26.
Scheduled sale ($6.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.08 | 16,694 | $2.0M | 31.3% |
| 2 | $120.08 | 16,694 | $2.0M | 31.3% |
| 3 | $120.03 | 20,000 | $2.4M | 37.5% |
| Total | $120.06 avg | 53,388 | $6.4M | 100% |
| Filing → |
| LQDA | SELL | 2026-05-28 | $400K | — | Filing → |
| LQDA | SELL | 2026-05-26 | $4.6M | — | Filing → |
| LQDA | SELL | 2026-05-20 | $4.4M | — | Filing → |